Your browser doesn't support javascript.
loading
Clinical Implications of the Coexistence of Anemia and Diabetes Mellitus in the Elderly Population.
Michalak, S S; Wolny-Rokicka, E; Nowakowska, E; Michalak, M; Gil, L.
Affiliation
  • Michalak SS; Department of Pharmacology and Toxicology, Collegium Medicum, University of Zielona Gora, Zielona Gora, Poland.
  • Wolny-Rokicka E; Department of Radiotherapy, Multidisciplinary Hospital, Gorzow Wielkopolski, Poland.
  • Nowakowska E; Department of Pharmacology and Toxicology, Collegium Medicum, University of Zielona Gora, Zielona Gora, Poland.
  • Michalak M; Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznan, Poland.
  • Gil L; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
J Diabetes Res ; 2021: 8745968, 2021.
Article in En | MEDLINE | ID: mdl-34708130
ABSTRACT
Diabetes mellitus (DM) and also anemia are common in the elderly and have a negative impact on the clinical outcomes of patients. The coexistence of anemia and DM seems to be insufficiently recognized; therefore, the aim of our study is to analyze the incidence and clinical consequences of this coexistence, including mortality, in the population of people aged ≥60. A retrospective study was conducted on 981 primary care clinic patients aged ≥60 during 2013-2014. The prevalence of coexistence of DM and anemia (defined in accordance with WHO) and data on the incidence of comorbidities, hospitalization, medical procedures, and all-cause mortality were analyzed. In the study population, 25% had DM, while 5.4% had both DM and anemia. Peripheral artery disease (PAD) was found in 48 patients (4.89%) of the entire study population, more often in men (p < 0.001). Diabetic patients with anemia compared to nonanemic diabetics had more comorbidities (median 4 (4, 5) vs. 3 (2-4); p < 0.001)-PAD more often (p = 0.004), more hospitalization (median 2 (0-11) vs. 0 (0-11); p < 0.001), and more frequent medical procedures (e.g., percutaneous coronary intervention (p < 0.001), coronary artery bypass surgery (p = 0.027), arteriography (p < 0.001), and bypass surgery or endovascular treatments of lower limb ischemia (p < 0.001)). The cumulative survival of patients with both DM and anemia vs. nonanemic diabetics at 36 months was 86.4% vs. 99.3% (p < 0.001). A multivariate logistic regression model showed anemia to be a significant risk factor for death in diabetic patients (p = 0.013). Patients with both DM and anemia have more comorbidities than nonanemic diabetic patients; they are more often hospitalized, require medical procedures more frequently, and are at a higher risk of death. Effective treatment of anemia in patients with DM is advisable and may well improve the prognosis of patients.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mortality / Diabetes Mellitus / Anemia Type of study: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Diabetes Res Year: 2021 Document type: Article Affiliation country: Polonia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mortality / Diabetes Mellitus / Anemia Type of study: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Diabetes Res Year: 2021 Document type: Article Affiliation country: Polonia